The Net Margin of Hanall Biopharma Co Ltd (009420.KS) is -3.58%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | -3.58% |
| 2024-12-31 | -1.30% |
| 2023-12-31 | 2.60% |
| 2022-12-31 | 0.23% |
| 2021-12-31 | 8.76% |
| 2020-12-31 | 22.31% |
| 2019-12-31 | 17.68% |
| 2018-12-31 | 3.59% |
| 2017-12-31 | 6.90% |
| 2016-12-31 | 2.44% |